The Sinopharm vaccine has been given to 1,000,000 people in China.
60,000 across the globe have already taken the Sinopharm vaccine, including volunteers in Argentina, Russia and Saudi Arabia.
Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health said Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
“Several days ago we signaled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome,” said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to innoculate Americans against a supposedly devastating strain of swine flu ground to a halt after some 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru’s clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
If they are successful — which won’t be known until mid-2021 — the Peruvian government was expected to buy up to 20 million doses to inoculate two-thirds of its population.
Peru’s clinical trials of the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
If they are successful – which will not be known until mid-2021 – the government is expected to buy up to 20 million doses to inoculate two-thirds of the population.
Some 60,000 across the globe have already taken the Sinopharm vaccine, including volunteers in Argentina, Russia and Saudi Arabia.
Peru has one of the world’s highest per capita death rate from the virus, which, as of yesterday, has caused 36,499 deaths and 979,111 infections.
The pandemic has hit the South American country’s economy hard, with its gross domestic product plunging more than 30% in the second quarter. – AFP, December 12, 2020
December 11, 20207:28 AMUpdated 2 days ago
Egypt receives first batch of Sinopharm coronavirus vaccines
By Reuters Staff
CAIRO (Reuters) – Egypt received its first shipment of vaccines developed by China National Pharmaceutical Group (Sinopharm) late on Thursday and will get more deliveries soon, health officials said.
The shipment arrived at Cairo airport from the United Arab Emirates, which has been carrying out phase III clinical trials of the vaccine.
The UAE health ministry said this week that the Sinopharm vaccine had 86% efficacy, citing an interim analysis of the late-stage clinical trials.
The vaccine has already been used on about 1 million people in China in an emergency programme.
In Egypt the vaccine, taken in two doses 21 days apart, will be free of charge and the government will prioritise vaccinating medical staff and people with chronic diseases, health officials said.
It was unclear how many doses of the vaccine Egypt had ordered, but the health minister said there would be more shipments in the days to come.